Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Archivos Españoles de Urología (Ed. impresa)
versión impresa ISSN 0004-0614
Resumen
ARRATIA-MAQUEO, Jorge A.; CORTES-GONZALEZ, Jeff R.; GARZA-CORTES, Roberto y GOMEZ-GUERRA, Lauro S.. Prospective study of prostate cancer's detection rate at our hospital in Northeast Mexican patients with PSA values between 2.6 y 4 ng/ml. Arch. Esp. Urol. [online]. 2010, vol.63, n.4, pp.287-290. ISSN 0004-0614.
Objectives: To find the detection rate of prostate cancer (PCa) in our population with PSA values between 2.6 and 4 ng/ml. Methods: We included 33 consecutive patients with a median age of 66 years, that had a Transrectal Ultrasound (TRUS) guided biopsy with PSA between 2.6-4 ng/ml. Patients were divided into 2 groups. Group 1: patients with normal Digital Rectal Examination (DRE) and Group 2: Patients with DRE with asymmetry not definitive of PCa. Exclusion criteria: known history of PCa, intraepithelial neoplasia or Positive DRE. Statistical analysis: Chi square, t-student and Fischer exact test. Results: Twenty eight percent of the patients (9) had positive biopsy for PCa. Fifty six percent (5) were Gleason 6 and 44% (4) Gleason 7 (3+4). Group 1 had 59% (20) and Group 2 41% in. In Group 1 16% (3) had positive biopsy for PCa vs 46% (6) in group 2 (p 0.04) RR 3.07. Conclusions: There are traces that the detection rate in our population could be lower in comparison with what has been reported in the literature. DRE is crucial in the initial evaluation; asymmetry could increase 3 fold the risk of having PCa.
Palabras clave : Prostatic cancer; PSA; Biopsy.